New hope for brain infection: shorter drug combo tested in 240 patients
NCT ID NCT07227779
First seen Nov 16, 2025 · Last updated May 09, 2026 · Updated 13 times
Summary
This study tests a new combination of medicines (BPaLMZ) for tuberculous meningitis, a serious brain infection. 240 adults, including those living with HIV, will receive either the new combo or standard care. Researchers will compare survival and recovery of daily function over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOUS MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Infectious Diseases Institute
Kampala, Uganda
Contact Email: •••••@•••••
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.